DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714080501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040480

On Market Since

9/9/2003

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

+0.6%

3M

+1.2%

6M

-7.1%

1Y

-26.0%

3Y

-48.2%

5Y

-56.9%

All

-43.0%